Articles tagged with Respiratory Disorders
A new study published at ATS 2026 International Conference found that many patients who initially struggle to meet CPAP usage thresholds continue to use and benefit from the therapy. The research challenges long-held assumptions about CPAP adherence, suggesting that early struggles don't predict treatment failure.
A major new study has found that severe asthma patients are often battling other health conditions, with nearly all suffering from at least one major issue. The study identified three distinct profiles linked to how well asthma is controlled and the treatments needed, offering potential breakthroughs for improving care.
A new study found that switching to a nicotine e-cigarette reduces toxicant exposure and improves quitting rates, with the nicotine group having a higher chance of quitting entirely. The study's results suggest that nicotine e-cigarettes could serve as an effective off-ramp for smokers seeking to reduce their tobacco use.
A new study presents dual immunization against respiratory syncytial virus (RSV) using RSVpreF and nirsevimab, showing reduced hospitalizations among infants in France. The study found that this combined approach demonstrates potential for enhanced RSV prevention and protection
A study led by University of Arizona researchers found that azithromycin did not improve symptoms in preschool children with severe wheezing. The trial results challenge the idea that certain types of bacteria contribute to wheezing and asthma, suggesting that viral infections play a more significant role.
A new study finds that pediatric pulmonary rehabilitation significantly improves exercise capacity, strength, and quality of life in children with chronic respiratory diseases. Spirometry, a key measure of lung function, remains stable but doesn't improve. The program is also associated with high patient and caregiver satisfaction.
A new study shows that New York City's public housing mold intervention program significantly reduces asthma-related emergency department visits. The program, Mold Busters, improved ventilation and trained staff in evidence-based mold removal, leading to a 9 fewer asthma-related ED visits per thousand people.
A new study quantifies the economic burden of tuberculosis, revealing that it costs the world an estimated $1.35 trillion annually. The disease disproportionately affects economically productive years, trapping families in poverty and impacting workforce participation and national development.
A new study suggests that a visual measure of illness perception can effectively convey symptom-related quality of life for patients with chronic lung illnesses. The study found that patients' visual perceptions of their lung disease were equally effective as standard questionnaires and test results in predicting quality of life.
The American Thoracic Society has launched a quality improvement initiative to tackle the underdiagnosis of bronchiectasis in the US. The study aims to investigate the scope of the problem and drive meaningful change in how the disease is identified and managed.
The RURAL Cohort Study aims to understand why residents of rural communities experience higher rates of heart, lung, and blood-related diseases, as well as shorter life expectancy and less-than-optimal overall health outcomes. The study uses a custom-built mobile examination unit to bring research directly to the community doorstep.
A national survey of Australian tunnel construction workers found significant silica dust exposure risks, with many reporting barriers to effective dust control measures. The study calls for stronger regulatory enforcement and oversight to prevent preventable disease in the high-risk industry.
Johns Hopkins researchers have identified a club cell-specific role for the protein RhoA in asthma airway inflammation. The study demonstrates how RhoA can be selectively targeted to prevent asthma-related complications, and offers new details on a potential cell-specific therapeutic target.
Researchers identified blocking ID1 and ID3 as a promising therapeutic strategy to halt and reverse lung scarring in idiopathic pulmonary fibrosis. The approach showed significant reduction in lung scarring and improvement in lung function across multiple experimental systems.
The number of pediatric lung transplants is expected to decline as highly effective therapies for cystic fibrosis reduce the need for transplantation. Complex cases with multi-system disease and severe cardiopulmonary compromise are on the rise, requiring highly specialized teams and close collaboration.
A landmark trial presented at ESCMID Global 2026 finds that improving oral hygiene for hospital patients reduces the risk of non-ventilator-associated hospital-acquired pneumonia (NV-HAP) by 60%. The study, involving over 8,000 patients, shows a substantial improvement in oral care practices among hospital patients.
Researchers developed an inhaled treatment to reduce lung inflammation and fluid build-up after severe infections. The therapy targets Angiopoietin-like protein 4 (ANGPTL4) and showed promise in preclinical studies.
A recent study published in Respiratory Physiology & Neurobiology found that breathing therapy devices don't affect all parts of the airway equally, with some areas experiencing stronger pressure and friction. The research provides valuable insights into how to improve device settings for patients with respiratory disorders.
A study estimates that quitting tobacco could give a major economic uplift to over 20 million households in India, with the greatest impact felt in rural areas and among the poorest households. The analysis suggests that these households would receive a significant boost in income, potentially moving up one or two economic classes.
A new study found that maintaining a healthy weight from early adulthood is associated with lower risks of premature death from various diseases. Excess weight at 25 years old has lasting effects on mortality risk, independent of subsequent weight changes.
Inuit communities in Nunavik, Quebec, are facing a devastating tuberculosis epidemic, with rates 1000 times higher than non-Inuit populations. The study's findings highlight the need for increased healthcare resourcing and community-led initiatives to address this crisis.
A meta-analysis of GLP-1 receptor agonist studies found potential safety signals for gastrointestinal side effects, while some evidence suggested a link to reduced respiratory disease risk. Further research is needed to confirm the latter association.
Researchers identify DNASE1L2 intron retention as a biomarker for TB progression and reveal its role in regulating inflammation. The study shows that upregulation of DNASE1L2-IR promotes host clearance of pathogen DNA, while downregulation weakens this antibacterial defense mechanism.
Research found that people who spend a higher proportion of their total physical activity doing vigorous activity have substantially lower risks of all eight serious health conditions. The benefits of vigorous activity remained even when the amount of time was modest.
A new study by UC San Francisco reveals that aging lung tissue can lead to catastrophic immune dysregulation, causing elderly individuals to become severely ill. The research suggests that targeting the damaged spiral of inflammaging could provide a promising therapeutic target for treating age-related respiratory diseases.
A new set of evidence-based clinical guidelines has been developed to manage recurrent wheezing in infants and toddlers. The guidelines recommend standardized protocols for diagnosing and treating the condition, including laboratory tests and type 2 inflammatory disease testing.
The ATS 2026 International Conference will feature the ATS AI Lab Exposition Space, highlighting advancements in AI in healthcare. Keynote speakers Robert M. Wachter and Laurah Turner will discuss AI's impact on medical education and its future.
The European Region is struggling to detect and treat tuberculosis, with 1 in 5 cases going undiagnosed or unreported. Drug-resistant strains are also a major concern, with the region accounting for a disproportionate share of global cases.
Decisions on extracorporeal membrane oxygenation (ECMO) for severe respiratory failure rely heavily on clinical judgments rather than objective guidelines. Variability in decision-making may lead to inconsistent allocation of this life-supporting treatment. The study aims to improve ECMO accessibility and equity.
A UK-led clinical trial found that surfactant treatment offers no benefit for infants on life support with severe bronchiolitis. The treatment was designed to improve recovery for critically ill babies, but the evidence does not support this.
A recent study has uncovered a dynamic spleen-to-lung neutrophil axis that operates during antiviral defense, challenging traditional views of pulmonary neutrophil origin. The study found that splenic neutrophils migrate to the lung, replenishing local pools and participating in innate immune defense.
Using azithromycin within one day triggers antibiotic resistance in the respiratory tract, according to a study published in Nature Microbiology. The researchers followed hospitalized COVID-19 patients and found that azithromycin changed the mix of microbes in the upper airway, leading to persistent changes for more than a week.
Researchers found that patients with both COPD and sleep apnea had significantly lower muscle strength and functional capacity compared to those with isolated COPD. The study highlights the importance of monitoring sleep-disordered breathing in the COPD population to improve quality of life.
Researchers evaluated 12 hypnotic medications on sleep architecture and respiratory function in adults with obstructive sleep apnea. The study found that while some medications worsened respiratory outcomes, others showed no significant effects, highlighting the need for individualized treatment.
A new study published in PLOS Medicine found that power outages in the US are associated with increased emergency hospital visits for older adults, particularly for cardiovascular and respiratory diseases. The study estimated that 4,246 additional hospitalizations occurred in 2018 among adults over 65 due to power outages.
Severe COVID-19 and influenza infections can prime the lungs for cancer development, according to new research. Vaccination, however, largely prevents these changes, suggesting a reduced risk of lung cancer.
A new study warns that reduced international funding for tuberculosis services could lead to significant economic hardship for 40 million households globally, with the poorest households bearing the greatest burden. The study estimates that complete elimination of external funding for TB could cost families up to $80 billion annually.
Rutgers researchers helped establish a link between burn pit exposure and respiratory illnesses in veterans, enabling the VA to adopt new rules implementing the PACT Act. The new methodology assigns graded levels of confidence, providing a path forward for evaluating service-related illnesses.
A new study shows that valved holding chambers used to deliver medication to children with acute respiratory diseases differ markedly in their performance. The choice of device can affect treatment outcomes, with higher delivery devices resulting in lower hospital admissions and better physiological recovery.
Co-infection of Cryptococcus neoformans and Mycobacterium tuberculosis increases risk of death significantly compared to fungal infection alone. The fungus changes its cell density, diversity, and capsule size in response to the bacterial pathogen.
A study published in JAMA Network Open found that early hydrocortisone treatment increases the chance of surviving without lung disease for extremely premature babies. The treatment is safe and does not increase serious side effects.
A new review highlights the cytokine storm's key role in lung injury and multi-organ dysfunction in acute respiratory distress syndrome (ARDS). The review emphasizes biological heterogeneity, subphenotypes, and the need for biomarker-guided patient stratification.
UCLA researchers have developed a novel gene-editing approach using lipid nanoparticles to deliver a full-length CFTR gene into human airway cells. The study shows promise for treating cystic fibrosis by correcting the underlying genetic mutation, which could lead to more effective and long-term therapies.
New research suggests that inhaled microplastics can cause inflammation and damage to the lungs, potentially increasing the risk of respiratory diseases such as asthma and COPD. Microplastics can also trigger inflammatory responses and deliver toxins directly into the lungs, highlighting a growing concern for lung health.
A new study has confirmed that male and female lungs are wired differently at the molecular level, revealing key gene networks driving sex differences in respiratory health. The research found that male lungs are more reactive to environmental triggers, leading to different disease experiences between sexes.
A one- and three-month antibiotic treatment regimens both had few adverse reactions and high rates of completion in preventing active tuberculosis, says a new study published in PLOS Medicine. The regimens were deemed successful and neither proved superior to the other.
A new study found that tuberculosis is a major cause of deadly sepsis among people living with HIV, particularly in Africa. Early treatment of TB has been shown to significantly reduce sepsis deaths, with a 23% reduction in mortality rate.
A recent study found that respiratory syncytial virus (RSV) hospitalizations are associated with a higher risk of cardiorespiratory events, with some conditions experiencing elevated risks up to 180 days after admission. The findings highlight the importance of increasing RSV immunization in adults to mitigate this risk.
A recent study found significant changes in post-COVID respiratory infections among children, with Mycoplasma pneumoniae experiencing a surge after restrictions were lifted. The study also revealed strong interactions between pathogens, including negative correlations and pathogen interference.
A sweeping new study has identified tuberculosis as the predominant cause of deadly sepsis among people with HIV in Africa. Immediate treatment for TB significantly increased survival rates, especially when treatment was started before diagnosis.
Researchers have created an artificial lung system that temporarily replaced a patient's lungs' functions, allowing him to survive for 48 hours until a double lung transplant was available. The study shows that this approach may serve as a life-saving bridge to transplantation, providing new hope for those with severe respiratory condi...
Current smokers are more likely to experience four symptoms associated with Long COVID, including arthralgia, chest pain and dyspnea. Dual users of combustible and heated tobacco products also show a stronger correlation with symptoms, suggesting the added use may worsen symptoms.
The American College of Chest Physicians (CHEST) received the 2025 Glenview Environmental Sustainability Award for Innovation, recognizing its commitment to clean energy and reduced emissions. The organization's solar panel installation at its headquarters powers medical simulation facilities using renewable energy.
Researchers created lab-grown human nasal tissue to study the defense mechanisms against rhinoviruses. They found that cells in the nasal lining produce interferons, which induce a coordinated antiviral defense, controlling viral replication and reducing damage.
Researchers have identified a new method to predict asthma exacerbations with a high degree of accuracy, analyzing data from three large asthma cohorts. The study found that the ratio between sphingolipids and steroids was the most powerful predictor of future health.
The American College of Chest Physicians released a new clinical guideline on biologic management in severe asthma. The guideline provides evidence-based recommendations for selecting biologics for different patient populations, considering factors such as baseline oral corticosteroid use and comorbid conditions.
Researchers have discovered that TB bacteria manipulate the immune system's Dectin-1 receptor to facilitate its survival. The study found that when this pathway is absent, both human and mouse cells can control MTB infection. This breakthrough provides new insight into why humans and animals are susceptible to contracting tuberculosis.